Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin aggregates in the hyperkeratotic stratum corneum represent a pathological accumulation of keratinized cells and proteins, leading to a thickened and often dysfunctional skin barrier. In healthy skin, keratinocytes undergo a programmed process of differentiation and desquamation; however, in hyperkeratotic conditions, this balance is disrupted, resulting in the formation of dense, hard keratin structures. These aggregates are a hallmark of various dermatological disorders, including psoriasis, ichthyosis, and common calluses. Therapeutic intervention typically involves the use of keratolytic agents, which work by breaking down the protein bonds within the keratin matrix or by increasing the hydration of the stratum corneum to facilitate shedding. By targeting these aggregates, treatments aim to restore normal skin texture, improve barrier function, and alleviate symptoms such as scaling and itching. Understanding the composition and physical properties of these aggregates is crucial for developing effective topical formulations that can penetrate the thickened epidermis.
Keratolytic agents act by disrupting the intercellular bonds (desmosomes) between corneocytes or by denaturing and hydrating the keratin protein matrix, which facilitates the softening and shedding of the thickened stratum corneum.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin aggregates in hyperkeratotic stratum corneum.